BDSX Q3 2023 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q3 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$13M+21.5% YoY

Gross Profit

$10M76.1% margin

Operating Income

-$7M-53.2% margin

Net Income

-$11M-81.2% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

+13.6%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$10M

Stock-Based Comp.

$954,000

Balance Sheet

Total Assets

$87M

Total Liabilities

$88M

Stockholders' Equity

-$1M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$11M	+21.5%
Gross Profit	$10M	$7M	+37.3%
Operating Income	-$7M	-$11M	+32.4%
Net Income	-$11M	-$14M	+20.1%

Revenue Segments

Diagnostic Tests

$12M91%

Service

$1M9%